Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.
USOR 24152 - Ph3 study of ARTEMIDE-GASTRIC01 in combo with pembro FIL gastric cancer
A Randomized, Phase III Study of Rilvegostomig in Combination with Fluoropyrimidine and Trastuzumab Deruxtecan versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First line Treatment of HER2-positive Gastric Cancer.
Disease Types: Gastric
Available at: Arlington Heights, Chicago, Niles